HBM4EU

from Wikipedia, the free encyclopedia

HBM4EU is a European research project with the aim of establishing a Europe-wide human biomonitoring .

Project goals

The initiative aims to help improve the health and well-being of citizens by studying how exposure to environmental chemicals affects the health of different groups of the population. The results are passed on to politicians (and political decision-makers) in order to improve the evidence base for the European Union's environmental and chemicals policy and thus to reduce the chemical pollution that is relevant to health.

Priority substances in the HBM4EU project (as of March 2019)

The work focuses on 18 substances or groups of substances that are toxicologically questionable and to which people across Europe are exposed through consumer products, cosmetics, food, the indoor and outdoor air and other environmental influences. Within the framework of HBM4EU, pollution and effects questions are answered for these priority substances.

The prioritized substances are:

Composition of the consortium (as of March 2019)

More than 110 partners from 28 countries (24 EU member states plus Norway, Iceland, Israel and Switzerland) are involved in the project. The consortium is managed by the German Federal Environment Agency .

advancement

The HBM4EU project has a term of 5 years - from 2017 to 2021 - and is co-financed by the European Commission as part of the Horizon 2020 funding program (Grant Agreement number 733032). The total financial volume of the project is around € 74 million.

Individual evidence

  1. a b HBM4EU - science and policy for a healthy future. Retrieved March 25, 2019 (UK English).
  2. Federal Environment Agency: HBM4EU: European Human Biomonitoring Initiative. November 7, 2017, accessed March 25, 2019 .
  3. Launch of the European Human Biomonitoring Initiative (# HBM4EU) | Research and Innovation - European Commission. Retrieved March 25, 2019 .